Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
BMC Cancer|June 5, 2013
Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun studyPhilipp Zimmer, Elke Jäger, Wilhelm Bloch, et al.
Cancer Research|June 29, 2012
Therapeutic administration of a synthetic CpG oligodeoxynucleotide triggers formation of anti-CpG antibodiesJulia Karbach, Antje Neumann, Claudia Wahle, et al.
Molecular Immunology|August 27, 2025
An indirect ELISA for the detection of anti-NY-ESO-1 antibodies in cancer patients and for monitoring cancer therapyJi Luo, Sanja Milkovska-Stamenova, Julia Karbach, et al.
American Journal of Clinical Oncology|February 6, 2009
Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stageDavid Felix Heigener, Christian Manegold, Elke Jäger, et al.
Medicine and Science in Sports and Exercise|June 9, 2025
Effects of Low-Load Blood Flow Restriction Training on Body Composition and Strength in Cancer Cachexia: A Case StudyFrieder Krause, Nils Schaffrath, Ingeborg Rötzer, et al.
Cancer Medicine|August 10, 2013
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinomaDominique Werner, Akin Atmaca, Claudia Pauligk, et al.
Oncology|June 17, 2011
Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancerAkin Atmaca, Claudia Pauligk, Kristina Steinmetz, et al.
Leukemia Research|April 13, 2010
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cellsMaika Almstedt, Nadja Blagitko-Dorfs, Jesús Duque-Afonso, et al.
Gynecologic Oncology|December 9, 2008
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II studyAkin Atmaca, Salah-Eddin Al-Batran, Antje Neumann, et al.
Cancer|March 23, 2007
Imatinib mesylate for targeting the platelet-derived growth factor beta receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer--a dose-escalation Phase I trialSalah-Eddin Al-Batran, Akin Atmaca, Eberhard Schleyer, et al.
Pageof 12